(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the preclinical CRO market lie in outsourcing R&D to streamline drug discovery and cut costs, with significant growth in AI-driven drug discovery. North America dominates, with high demand due to regulatory complexities and chronic diseases. Emerging markets like India show rapid growth in specialized services.

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share, Trends, and Forecast by Service, End Use, and Region, 2025-2033" has been added to ResearchAndMarkets's offering.

The global preclinical CRO market is projected to grow from USD 6.4 billion in 2024 to USD 11.3 billion by 2033, achieving a CAGR of 6.5%. North America leads this market with a 47.5% share in 2024, thanks to increased R&D investments, regulatory complexities, and specialized treatment advancements.

Driving this growth is the rising trend of outsourcing R&D to streamline drug discovery and cut costs. Pharmaceutical and biotech companies are increasingly relying on CROs for their specialized expertise, advanced technology, and comprehensive preclinical testing services. Additionally, the rise in chronic diseases and the need for faster drug development have increased the demand for preclinical CRO services. Technological progress, such as AI-driven drug discovery, is enhancing partnerships with CROs globally.

In the US, which holds a 93.7% share of the market, there's a growing trend of outsourcing preclinical research to CROs to reduce costs and accelerate drug development. The increasing prevalence of chronic diseases and the complexity of drug development are prompting companies to seek CRO expertise.

Preclinical CRO Market Trends

Rising Research and Development Activities: An increase in R&D within the pharmaceutical and biotechnology sectors is expanding the preclinical CRO market. A complex drug development process demands extensive preclinical testing for safety and efficacy. This has led to a surge in India's market, showing a 11.4% CAGR, driven by global outsourcing demand and developed infrastructure. Outsourcing to CROs helps pharmaceutical companies cut costs in preclinical R&D.

Complex Regulatory Environment: Extensive preclinical testing is required to meet FDA and EMA's regulatory standards, increasing the need for preclinical CRO services. CROs experienced in international regulations help pharmaceutical companies navigate these complex environments.

Increasing Cost of Drug Development: Drug development costs are rising due to its complex and time-consuming nature. CROs, with their specialized expertise, help mitigate development risks and costs by providing guidance in drug selection.

Preclinical CRO Industry Segmentation

Analysis by Service:

• Bioanalysis and DMPK Studies
• Toxicology Testing - The largest segment, accounting for 51.6% of the market in 2024, due to its pivotal role in ensuring drug safety.
• Others

Analysis by End Use:

• Biopharmaceutical Companies - The largest end-users in 2024, holding 81% market share, due to extensive preclinical research required for biologics and targeted therapies.
• Government and Academic Institutes
• Medical Device Companies

Regional Analysis:

• North America - Leads with 47.5% of the global share, fueled by significant R&D investments and technological advancements.
• Asia Pacific - Emerging as a hub for preclinical outsourcing, driven by cost-effective solutions and regulatory support.
• Europe, Latin America, Middle East, and Africa - Showing significant growth due to strategic investments and improved research infrastructure.

The global preclinical CRO market is highly competitive, with major players like Charles River Laboratories Inc., Covance Inc., and others expanding their service portfolios. Intense competition also comes from regional players targeting niche services and emerging markets.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Preclinical CRO Market

6 Market Breakup by Service

7 Market Breakup by End Use

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

• Charles River Laboratories Inc.
• Covance Inc. (Laboratory Corporation of America Holdings)
• Eurofins Scientific
• ICON Plc
• MD Biosciences Inc. (MLM Medical Labs)
• Medpace
• Parexel International Corporation
• PPD Inc.
• Wuxi AppTec

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN03112025004107003653ID1110285996